T Cells Th1/Th2 cells EAE/MS Cytokines Transgenic/knockout mice T helper 2 (Th2) cytokines are known to be important in protection against experimental autoimmune encephalomyelitis (EAE). To investigate the role of the signal transducer and activator of transcription factor 6 (STAT6) in EAE we used mice with two different targeted disruptions of the STAT6 gene. In this report, we show that mice with a targeted deletion of the first coding exon of the SH2 domain of STAT6 induce Th2 cell differentiation and are resistant to EAE induction. By contrast, STAT6 −/− mice generated by deletion of amino acids 505 to 584 encoding the SH2 domain of STAT6 are defective in Th2 cell differentiation and develop very severe EAE. These results suggest that an altered STAT6 gene can be more efficient than wild type STAT6 in regulating the autoimmune response in EAE.
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Introduction
Upon encountering antigen, naïve CD4 + T cells can differentiate into three distinct subsets, Th1, Th2 or Th17, that are distinguished by their cytokine expression profiles (Romagnani, 2006; Stummvoll et al., 2008) . Th1 cells produce IFN-γ, IL-2 and TNF-α, while Th2 cells produce IL-4, IL-5 and IL-13 and Th17 cells produce IL-17 and IL-22 (Kurts, 2008) . In addition to their cytokine profiles, Th1, Th2 and Th17 cells possess a signature array of transcription factors. T-bet and STAT1 1 are required for the development of IFN-γ-producing CD4 Th1 cells while STAT6 and GATA-3 are essential for the development of Th2 cells (Kurts, 2008) . RORγt has been shown to be an essential transcription factor for development of the Th17 subset (Weaver et al., 2006) . Recent studies show that T-bet, which plays an essential role in Th1 cells development, is also expressed in IL-17 producing cells and influences the development of Th17 cells (Gocke et al., 2007) .
Both IL-4 and IL-13 signaling are regulated by STAT6, a Th2 signaling molecule known to have over 30 target genes (Hebenstreit et al., 2006) . Following IL-4 receptor engagement, Janus Kinases (JAK1 and JAK3) phosphorylate the cytoplasmic tail of the receptor, recruiting STAT6, which is subsequently phosphorylated by the same JAKs. STAT6 then dimerizes and translocates to the nucleus, where it is able to upregulate IL-4 responsive gene transcription (Hebenstreit et al., 2006; Kurata et al., 1999) . The STAT6 pathway contributes to the increasingly stable expression of Th2 cytokines, thereby regulating Th2 development. The mechanism by which STAT6 mediates development of Th2 responses is not completely understood, but the transcription factor has a central role in the progressive changes in chromatin structure of the IL-4, IL-5 and IL-13 loci during Th2 differentiation (Agarwal and Rao, 1998; Fields et al., 2002) as well as the stable up-regulation of GATA3 (Ouyang et al., 2000; Ouyang et al., 1998) .
Experimental autoimmune encephalomyelitis (EAE) is a chronic autoimmune disease of the central nervous system (CNS) induced in susceptible mouse strains. EAE bears many of the clinical and pathological features of MS and is considered a viable model for the disease. In mice, EAE can be actively induced in susceptible mouse strains following immunization with myelin components, such as myelin basic protein (MBP), proteolipid protein (PLP), or myelin oligodendrocyte glycoprotein (MOG), or by passive transfer of myelin antigen-specific T cells (Buenafe et al., 1997; Wekerle et al., 1994) . These antigen-specific activated T cells, which are mostly CD4 positive, differentiate into effector Th1 or Th17 cells that migrate to the CNS 
